ProteinQure

ProteinQure is a clinical-stage biotech company focused on the design of novel exotic peptides with broad therapeutic applications. Its approach leverages peptide-drug conjugates to enable precise tissue- and cell-specific delivery of therapeutics. At the core of this innovation is ProteinStudio™, a proprietary computational platform that combines predictive power with deep structural insights into peptides and proteins. The company's lead program, PQ203, is being evaluated in a Phase 1 clinical trial for advanced solid tumors.

ProteinQure is a clinical-stage biotech company focused on the design of novel exotic peptides with broad therapeutic applications. The company recently announced the first clinical trial of a fully AI-designed peptide-drug conjugate in Canada and the United States. Its approach leverages peptide-drug conjugates to enable precise tissue- and cell-specific delivery of therapeutics. At the core of this innovation is ProteinStudio™, a proprietary computational platform that combines predictive power with deep structural insights into peptides and proteins. The platform supports the development of novel strategies for therapeutic payload delivery. The company's lead program, PQ203, is currently being evaluated in a Phase 1 clinical trial for advanced solid tumors—marking a milestone in the application of AI to peptide drug design.

ProteinQure is the pioneering champion of computational peptide drug design, powered by atomic-level simulations and artificial intelligence.

1. 1ProteinQureproteinqure.com
2. 2ProteinQure - Companyproteinqure.com